Side Effects of Adjuvant Chemotherapy: Perceptions of Node-Negative Breast Cancer Patients
β Scribed by Analee E. Beisecker; Mary R. Cook; Janet Ashworth; Jeanne Hayes; Marci Brecheisen; Linda Helmig; Siobhan Hyland; Darcy Selenke
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 52 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1057-9249
No coin nor oath required. For personal study only.
β¦ Synopsis
Twenty-one node-negative breast cancer patients were interviewed shortly after completing adjuvant chemotherapy and asked about side effects they had experienced, expectation of side effects, and strategies for coping with the side effects. Eighteen of the women were interviewed 6 months later to determine their feelings about the chemotherapy experience and ending treatment and what side effects persisted or developed after chemotherapy. Hair loss, fatigue, treatment-related problems, nausea and infections/low blood counts were the most frequently described problems during the first interviews. Patients used coping strategies suggested by physicians and nurses. Six months later, hair problems, fatigue, weight gain, menopausal problems, emotional problems and nail problems were most often reported. Most patients (16/18) did not expect to be experiencing chemotherapy-related problems 6 months after ending treatment. Fatigue interfered with daily lives and weight gain caused concern. A total of 35% of participants experienced fear or anxiety at the end of chemotherapy, but most (62%) recalled at least some positive feelings 6 months later. Given the same circumstances, all but two would make the same decision to undergo adjuvant chemotherapy. Support groups would be especially useful for patients completing chemotherapy who would lose continued frequent support from clinic personnel.
π SIMILAR VOLUMES
The aim of this study was to examine the cellular distribution of osteopontin (OPN) protein [by immunohistochemical (IHC) analysis] and mRNA [by in situ hybridization (ISH)] in the primary tumors of lymph node negative (LNN) breast cancer patients and to determine whether the level of immunodetectab
## BACKGROUND. Amplification of certain genes is involved in resistance to chertiotherapy. The development of such amplification in patients by drug treatment has not yet been established. We have assessed the appearance of gene amplification in breast cancer patients with recurrent disease. One g
## Background and Objectives: The objectives of this study were to confirm the favorable outcome of Japanese invasive breast cancer patients without lymph node metastasis, after treatment with surgery alone, and to evaluate clinicopathological prognostic factors in this population. Methods: The sub